I Screpanti
Overview
Explore the profile of I Screpanti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
1644
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsaouli G, Barbarulo A, Vacca A, Screpanti I, Felli M
Adv Exp Med Biol
. 2020 Feb;
1227:145-164.
PMID: 32072504
Notch is a ligand-receptor interaction-triggered signaling cascade highly conserved, that influences multiple lineage decisions within the hematopoietic and the immune system. It is a recognized model of intercellular communication that...
2.
Giuli M, Giuliani E, Screpanti I, Bellavia D, Checquolo S
J Oncol
. 2019 Aug;
2019:8707053.
PMID: 31379945
Triple-negative breast cancer (TNBC) is a subgroup of 15%-20% of diagnosed breast cancer patients. It is generally considered to be the most difficult breast cancer subtype to deal with, due...
3.
Colicchia V, Petroni M, Guarguaglini G, Sardina F, Sahun-Roncero M, Carbonari M, et al.
Oncogene
. 2017 Apr;
36(33):4682-4691.
PMID: 28394338
High-risk and MYCN-amplified neuroblastomas are among the most aggressive pediatric tumors. Despite intense multimodality therapies, about 50% of these patients succumb to their disease, making the search for effective therapies...
4.
Po A, Silvano M, Miele E, Capalbo C, Eramo A, Salvati V, et al.
Oncogene
. 2017 Apr;
36(32):4641-4652.
PMID: 28368412
Aberrant Hedgehog/GLI signaling has been implicated in a diverse spectrum of human cancers, but its role in lung adenocarcinoma (LAC) is still under debate. We show that the downstream effector...
5.
Franciosa G, Diluvio G, Del Gaudio F, Giuli M, Palermo R, Grazioli P, et al.
Oncogene
. 2016 Feb;
35(36):4741-51.
PMID: 26876201
Deregulated Notch signaling is associated with T-cell Acute Lymphoblastic Leukemia (T-ALL) development and progression. Increasing evidence reveals that Notch pathway has an important role in the invasion ability of tumor...
6.
Petroni M, Sardina F, Heil C, Sahun-Roncero M, Colicchia V, Veschi V, et al.
Cell Death Differ
. 2015 Jun;
23(2):197-206.
PMID: 26068589
The MRE11/RAD50/NBS1 (MRN) complex is a major sensor of DNA double strand breaks, whose role in controlling faithful DNA replication and preventing replication stress is also emerging. Inactivation of the...
7.
Vargas Romero P, Cialfi S, Palermo R, De Blasio C, Checquolo S, Bellavia D, et al.
Leukemia
. 2015 May;
29(12):2442-5.
PMID: 25982911
No abstract available.
8.
De Falco F, Sabatini R, Falzetti F, Di Ianni M, Sportoletti P, Baldoni S, et al.
Leukemia
. 2014 Nov;
29(4):994-8.
PMID: 25425197
No abstract available.
9.
Martin-Blanco N, Checquolo S, Del Gaudio F, Palermo R, Franciosa G, Di Marcotullio L, et al.
Cell Death Dis
. 2014 Oct;
5:e1472.
PMID: 25321479
Numb asymmetrically segregates at mitosis to control cell fate choices during development. Numb inheritance specifies progenitor over differentiated cell fates, and, paradoxically, also promotes neuronal differentiation, thus indicating that the...
10.
Kumar V, Palermo R, Talora C, Campese A, Checquolo S, Bellavia D, et al.
Leukemia
. 2014 Apr;
28(12):2324-35.
PMID: 24727676
Notch signaling deregulation is linked to the onset of several tumors including T-cell acute lymphoblastic leukemia (T-ALL). Deregulated microRNA (miRNA) expression is also associated with several cancers, including leukemias. However,...